HighTower Advisors
CFRX

HighTower Advisors’s ContraFect Corporation CFRX Stock Holding History

HighTower Advisors’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-125
Closed -$7K – 3558
2021
Q2 		$7K Buy
+125
New +$40.9K ﹤0.01% 3022

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighTower Advisors's CFRX Position: Q4 2021 in Review

HighTower Advisors sold out of ContraFect Corporation (CFRX) in Q4 2021, closing a stake of 263 shares — an estimated $85K sold.

HighTower Advisors first reported a position in CFRX in Q4 2020 and held it in 4 quarters. The position peaked at $135K in Q1 2021. 59 funds tracked by Wall St. Rank hold CFRX as of Q4 2021.

  • HighTower Advisors reported no remaining ContraFect Corporation position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 263 ContraFect Corporation shares in Q4 2021, an estimated $85K.
  • HighTower Advisors first reported a position in ContraFect Corporation in Q4 2020 and held it in 4 quarters.
  • HighTower Advisors's ContraFect Corporation position peaked at $135K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.